New: NCI-funded clinical trial search
Mednet Logo
CommunityGynecologic Oncology

Do you routinely perform bilateral oophorectomy at the time of hysterectomy for a premenopausal woman with a uterine leiomyosarcoma that appears to be limited to the uterus?

Does ER/PR status help guide your decision?
Community PollStarted

How do you manage a uterine leiomyosarcoma that appears to be limited to the uterus in a premenopausal woman?

22 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet MemberInvited Expert
Gynecologic Oncology · Medical University of South Carolina
Answered on

Since this is an unusual cancer, there is not a whole lot of data on this subject. Having said that, the literature has suggested that the chance of ovarian mets in a stage 1, 11 is 2-5%. As a result, this factor is not a major consideration in regards to survival. In a patient so presented, would not routinely do a BSO as the benefits of leaving them seem to outweigh removing possible micromets.

Most LMS are diagnosed in the path lab so doing a BSO at the time of hysterectomy in a premenopausal woman is probably not usually under consideration. I certainly would not go back and do a later BSO.

I don't think hormone status has any bearing on the subject. Unfortunately, this diagnosis carries a very limited prognosis so keep the patient comfortable--not hot flushes, sleepless nights, etc.